Delta4
@delta4ai.bsky.social
Delta4 is a TechBio company driving the forefront of digital drug discovery and indication expansion.
www.delta4.ai
www.delta4.ai
🔎 ADPKD is more than kidney cysts — it’s a systemic disease needing holistic care. With partners at MedUni Innsbruck, Delta4 builds on diagnostic insights to drive new therapies that slow cyst growth and address the wider health burden of #ADPKD patients. #KidneyHealth
November 27, 2025 at 8:57 AM
🔎 ADPKD is more than kidney cysts — it’s a systemic disease needing holistic care. With partners at MedUni Innsbruck, Delta4 builds on diagnostic insights to drive new therapies that slow cyst growth and address the wider health burden of #ADPKD patients. #KidneyHealth
Swapped our loft office for a Josefstadt seminar hotel 🔥 Full day of brainstorming, tackling challenges, and fueling Delta4’s next chapter together. #TeamDelta4 #InnovationInAction
November 24, 2025 at 12:35 PM
Swapped our loft office for a Josefstadt seminar hotel 🔥 Full day of brainstorming, tackling challenges, and fueling Delta4’s next chapter together. #TeamDelta4 #InnovationInAction
At Delta4, we foster the next generation of biotech innovators — supporting MSc & PhD researchers through EU MSCA projects like PROMOTE & PICKED and our in-house mentoring. #NextGenScience
November 21, 2025 at 10:00 AM
At Delta4, we foster the next generation of biotech innovators — supporting MSc & PhD researchers through EU MSCA projects like PROMOTE & PICKED and our in-house mentoring. #NextGenScience
On #WorldCOPDDay, we’re reminded that many chronic diseases still lack effective, personalized treatments. At Delta4, we use computational biotech to uncover new therapeutic opportunities.
November 19, 2025 at 10:40 AM
On #WorldCOPDDay, we’re reminded that many chronic diseases still lack effective, personalized treatments. At Delta4, we use computational biotech to uncover new therapeutic opportunities.
In our webinar with CLS, we showed how Hyper-C models reactive astrocytes, revealing neurotoxic mechanisms and drug repositioning opportunities for neuroprotection. Watch: youtu.be/19LP5EwSdb4
November 17, 2025 at 2:15 PM
In our webinar with CLS, we showed how Hyper-C models reactive astrocytes, revealing neurotoxic mechanisms and drug repositioning opportunities for neuroprotection. Watch: youtu.be/19LP5EwSdb4
FFG Success Story 🎉: Delta4 joins EU-funded PICKED to advance biomarkers & personalized therapies for CKD. Paul Perco: "EU projects like PICKED build networks & talent." www.ffg.at/success-stor...
November 13, 2025 at 9:13 AM
FFG Success Story 🎉: Delta4 joins EU-funded PICKED to advance biomarkers & personalized therapies for CKD. Paul Perco: "EU projects like PICKED build networks & talent." www.ffg.at/success-stor...
Science is stronger when everyone’s voice is heard. At Delta4, we’re committed to creating a space where women can contribute, innovate, and make a lasting impact.
🌐 Learn more about our commitment!
delta4.ai/gender-equal...
#Delta4 #GenderEquality
🌐 Learn more about our commitment!
delta4.ai/gender-equal...
#Delta4 #GenderEquality
November 10, 2025 at 10:05 AM
Science is stronger when everyone’s voice is heard. At Delta4, we’re committed to creating a space where women can contribute, innovate, and make a lasting impact.
🌐 Learn more about our commitment!
delta4.ai/gender-equal...
#Delta4 #GenderEquality
🌐 Learn more about our commitment!
delta4.ai/gender-equal...
#Delta4 #GenderEquality
Solutions for Each Step of Your Pipeline! 🚀
Delta4 combines AI, biology, and drug development expertise to optimize your pipeline from start to finish.
Learn more here!
delta4.ai/development-...
#Delta4 #Pipeline
Delta4 combines AI, biology, and drug development expertise to optimize your pipeline from start to finish.
Learn more here!
delta4.ai/development-...
#Delta4 #Pipeline
November 4, 2025 at 10:15 AM
Solutions for Each Step of Your Pipeline! 🚀
Delta4 combines AI, biology, and drug development expertise to optimize your pipeline from start to finish.
Learn more here!
delta4.ai/development-...
#Delta4 #Pipeline
Delta4 combines AI, biology, and drug development expertise to optimize your pipeline from start to finish.
Learn more here!
delta4.ai/development-...
#Delta4 #Pipeline
Just a few days to go!📣
Delta4 will be at BIO-Europe 2025 in Vienna, Nov 3–5.
Meet our CSO, Dr. Klaus Kratochwill, and discover how our Hyper-C platform can help unlock new therapeutic opportunities.
📩 DM us to schedule a meeting at the conference!
Delta4 will be at BIO-Europe 2025 in Vienna, Nov 3–5.
Meet our CSO, Dr. Klaus Kratochwill, and discover how our Hyper-C platform can help unlock new therapeutic opportunities.
📩 DM us to schedule a meeting at the conference!
November 1, 2025 at 8:00 AM
Just a few days to go!📣
Delta4 will be at BIO-Europe 2025 in Vienna, Nov 3–5.
Meet our CSO, Dr. Klaus Kratochwill, and discover how our Hyper-C platform can help unlock new therapeutic opportunities.
📩 DM us to schedule a meeting at the conference!
Delta4 will be at BIO-Europe 2025 in Vienna, Nov 3–5.
Meet our CSO, Dr. Klaus Kratochwill, and discover how our Hyper-C platform can help unlock new therapeutic opportunities.
📩 DM us to schedule a meeting at the conference!
👻 This Halloween, we’re shining a light on the eerie side of drug development, highlighting the unseen challenges: from ghost targets to haunted orphan diseases. At Delta4, we turn the spooky into science, uncovering real therapeutic opportunities hidden beneath the (sometimes misleading) surface.
October 31, 2025 at 8:00 AM
👻 This Halloween, we’re shining a light on the eerie side of drug development, highlighting the unseen challenges: from ghost targets to haunted orphan diseases. At Delta4, we turn the spooky into science, uncovering real therapeutic opportunities hidden beneath the (sometimes misleading) surface.
🧬October 26th is #Amyloidosis Day🧬
🔍 At the molecular level, amyloidosis represents a convergence of protein misfolding, proteostasis imbalance, and chronic inflammation. Our Hyper-C platform is modeling diseases as dynamic molecular networks to find new solutions for such complex diseases.
🔍 At the molecular level, amyloidosis represents a convergence of protein misfolding, proteostasis imbalance, and chronic inflammation. Our Hyper-C platform is modeling diseases as dynamic molecular networks to find new solutions for such complex diseases.
October 26, 2025 at 8:00 AM
🧬October 26th is #Amyloidosis Day🧬
🔍 At the molecular level, amyloidosis represents a convergence of protein misfolding, proteostasis imbalance, and chronic inflammation. Our Hyper-C platform is modeling diseases as dynamic molecular networks to find new solutions for such complex diseases.
🔍 At the molecular level, amyloidosis represents a convergence of protein misfolding, proteostasis imbalance, and chronic inflammation. Our Hyper-C platform is modeling diseases as dynamic molecular networks to find new solutions for such complex diseases.
Delta4 hosted a Bioinformatics & -statistics Workshop in Vienna, bringing together PhD students to elevate their CKD research. Learn more: delta4.ai/personalized...
#Delta4 #PICKEDProject
#Delta4 #PICKEDProject
October 24, 2025 at 8:00 AM
Delta4 hosted a Bioinformatics & -statistics Workshop in Vienna, bringing together PhD students to elevate their CKD research. Learn more: delta4.ai/personalized...
#Delta4 #PICKEDProject
#Delta4 #PICKEDProject
Rare diseases may be complex, but every patient deserves hope, answers, and action.
At Delta4, we harness the power of AI-supported drug repurposing to accelerate breakthroughs and bring new possibilities to those who need them most.
Together, we can change the future of rare disease care.
#Delta4
At Delta4, we harness the power of AI-supported drug repurposing to accelerate breakthroughs and bring new possibilities to those who need them most.
Together, we can change the future of rare disease care.
#Delta4
October 23, 2025 at 10:20 AM
Rare diseases may be complex, but every patient deserves hope, answers, and action.
At Delta4, we harness the power of AI-supported drug repurposing to accelerate breakthroughs and bring new possibilities to those who need them most.
Together, we can change the future of rare disease care.
#Delta4
At Delta4, we harness the power of AI-supported drug repurposing to accelerate breakthroughs and bring new possibilities to those who need them most.
Together, we can change the future of rare disease care.
#Delta4
🧬 At Delta4, we turn omics data into actionable insights. By integrating multi-omics layers into our Hyper-C platform, we simulate disease mechanisms, predict drug responses, and uncover new indications — advancing precision drug repositioning for complex and rare diseases.
#AIinBiotech
#AIinBiotech
October 16, 2025 at 1:00 PM
🧬 At Delta4, we turn omics data into actionable insights. By integrating multi-omics layers into our Hyper-C platform, we simulate disease mechanisms, predict drug responses, and uncover new indications — advancing precision drug repositioning for complex and rare diseases.
#AIinBiotech
#AIinBiotech
Delta4 at BIO-Europe 2025 | Vienna
Looking to expand indications, identify new targets, or discover innovative drug combinations? Meet our CSO and explore how we can unlock new therapeutic opportunities with the help of our platform, Hyper-C.
📩 DM us to schedule a meeting at the conference!
Looking to expand indications, identify new targets, or discover innovative drug combinations? Meet our CSO and explore how we can unlock new therapeutic opportunities with the help of our platform, Hyper-C.
📩 DM us to schedule a meeting at the conference!
October 13, 2025 at 8:50 AM
Delta4 at BIO-Europe 2025 | Vienna
Looking to expand indications, identify new targets, or discover innovative drug combinations? Meet our CSO and explore how we can unlock new therapeutic opportunities with the help of our platform, Hyper-C.
📩 DM us to schedule a meeting at the conference!
Looking to expand indications, identify new targets, or discover innovative drug combinations? Meet our CSO and explore how we can unlock new therapeutic opportunities with the help of our platform, Hyper-C.
📩 DM us to schedule a meeting at the conference!
🌍 Living with a rare or chronic disease affects more than the body, it deeply impacts mental health. On #WorldMentalHealthDay, we at Delta4 stand with patients and families, driving innovation in drug repurposing to ease both physical and emotional burdens. 💚 #MentalHealth
October 10, 2025 at 7:20 AM
🌍 Living with a rare or chronic disease affects more than the body, it deeply impacts mental health. On #WorldMentalHealthDay, we at Delta4 stand with patients and families, driving innovation in drug repurposing to ease both physical and emotional burdens. 💚 #MentalHealth
Our in-silico drug repositioning platform moves beyond narrow-scope tasks. We integrate multimodal biological data – from omics to phenotypes – to capture the complexity of disease biology at a systems level.
Learn more about how we’re changing the game in drug repurposing: delta4.ai/development-...
Learn more about how we’re changing the game in drug repurposing: delta4.ai/development-...
October 7, 2025 at 2:00 PM
Our in-silico drug repositioning platform moves beyond narrow-scope tasks. We integrate multimodal biological data – from omics to phenotypes – to capture the complexity of disease biology at a systems level.
Learn more about how we’re changing the game in drug repurposing: delta4.ai/development-...
Learn more about how we’re changing the game in drug repurposing: delta4.ai/development-...
🔎 A New ISN ADPKD Toolkit standardizes diagnosis & risk assessment. At Delta4, we complement this with in-silico drug discovery, mapping disease mechanisms, prioritizing compounds & biomarkers to speed up effective therapies. #ADPKD #Nephrology #DrugDiscovery
October 3, 2025 at 8:48 AM
🔎 A New ISN ADPKD Toolkit standardizes diagnosis & risk assessment. At Delta4, we complement this with in-silico drug discovery, mapping disease mechanisms, prioritizing compounds & biomarkers to speed up effective therapies. #ADPKD #Nephrology #DrugDiscovery
The future of neurodegeneration research is here 🔍
Today, September 30th, join us and Concept Life Sciences for a webinar on:
"Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration".
👉 Register now and join the discussion: lnkd.in/ePUadeBE
Today, September 30th, join us and Concept Life Sciences for a webinar on:
"Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration".
👉 Register now and join the discussion: lnkd.in/ePUadeBE
September 30, 2025 at 8:40 AM
The future of neurodegeneration research is here 🔍
Today, September 30th, join us and Concept Life Sciences for a webinar on:
"Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration".
👉 Register now and join the discussion: lnkd.in/ePUadeBE
Today, September 30th, join us and Concept Life Sciences for a webinar on:
"Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration".
👉 Register now and join the discussion: lnkd.in/ePUadeBE
💙 World Heart Day 2025
Repositioned drugs like SGLT2i, GLP1RAs, MRAs & ERAs show strong cardiorenal benefits. At Delta4, we advance this field with computational & biological insights. Read our Proteomics viewpoint:
analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/...
Repositioned drugs like SGLT2i, GLP1RAs, MRAs & ERAs show strong cardiorenal benefits. At Delta4, we advance this field with computational & biological insights. Read our Proteomics viewpoint:
analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/...
September 29, 2025 at 8:15 AM
💙 World Heart Day 2025
Repositioned drugs like SGLT2i, GLP1RAs, MRAs & ERAs show strong cardiorenal benefits. At Delta4, we advance this field with computational & biological insights. Read our Proteomics viewpoint:
analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/...
Repositioned drugs like SGLT2i, GLP1RAs, MRAs & ERAs show strong cardiorenal benefits. At Delta4, we advance this field with computational & biological insights. Read our Proteomics viewpoint:
analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/...
📢 Call for Papers!
Springer Nature launches a collection on molecular & imaging-guided precision intervention in #prostate #cancer, edited by Harald Mischak.
Submit work on biomarkers, AI-driven imaging, or targeted therapies. 🔗 link.springer.com/.
#CallForPapers
Springer Nature launches a collection on molecular & imaging-guided precision intervention in #prostate #cancer, edited by Harald Mischak.
Submit work on biomarkers, AI-driven imaging, or targeted therapies. 🔗 link.springer.com/.
#CallForPapers
September 24, 2025 at 6:58 PM
📢 Call for Papers!
Springer Nature launches a collection on molecular & imaging-guided precision intervention in #prostate #cancer, edited by Harald Mischak.
Submit work on biomarkers, AI-driven imaging, or targeted therapies. 🔗 link.springer.com/.
#CallForPapers
Springer Nature launches a collection on molecular & imaging-guided precision intervention in #prostate #cancer, edited by Harald Mischak.
Submit work on biomarkers, AI-driven imaging, or targeted therapies. 🔗 link.springer.com/.
#CallForPapers
🧠 World Alzheimer’s Day 2025
This day reminds us of the complexity of Alzheimer’s disease and the need to better understand the brain’s immune and support cells. Astrocytes are now seen as central players—join our Sept 30 webinar with Concept Life Sciences to learn more.
This day reminds us of the complexity of Alzheimer’s disease and the need to better understand the brain’s immune and support cells. Astrocytes are now seen as central players—join our Sept 30 webinar with Concept Life Sciences to learn more.
September 21, 2025 at 8:00 AM
🧠 World Alzheimer’s Day 2025
This day reminds us of the complexity of Alzheimer’s disease and the need to better understand the brain’s immune and support cells. Astrocytes are now seen as central players—join our Sept 30 webinar with Concept Life Sciences to learn more.
This day reminds us of the complexity of Alzheimer’s disease and the need to better understand the brain’s immune and support cells. Astrocytes are now seen as central players—join our Sept 30 webinar with Concept Life Sciences to learn more.
🚀 Our collaboration with Concept Life Sciences highlights new treatment avenues by targeting astrocytes.
Join us on Sept 30th to see how we combine neuroscience expertise with Delta4’s Hyper-C platform to identify novel targets in neurodegeneration!
📅 Register here: tinyurl.com/CNSwebinar25
Join us on Sept 30th to see how we combine neuroscience expertise with Delta4’s Hyper-C platform to identify novel targets in neurodegeneration!
📅 Register here: tinyurl.com/CNSwebinar25
September 19, 2025 at 9:23 AM
🚀 Our collaboration with Concept Life Sciences highlights new treatment avenues by targeting astrocytes.
Join us on Sept 30th to see how we combine neuroscience expertise with Delta4’s Hyper-C platform to identify novel targets in neurodegeneration!
📅 Register here: tinyurl.com/CNSwebinar25
Join us on Sept 30th to see how we combine neuroscience expertise with Delta4’s Hyper-C platform to identify novel targets in neurodegeneration!
📅 Register here: tinyurl.com/CNSwebinar25
🩸 World Sepsis Day 2025 | In sepsis care every moment counts to change and save lives.
We recognize that the fight against sepsis transcends acute care and is about leveraging innovation in computational research to deliver therapies faster, more safely, and tailored to patient needs.
We recognize that the fight against sepsis transcends acute care and is about leveraging innovation in computational research to deliver therapies faster, more safely, and tailored to patient needs.
September 13, 2025 at 8:00 AM
🩸 World Sepsis Day 2025 | In sepsis care every moment counts to change and save lives.
We recognize that the fight against sepsis transcends acute care and is about leveraging innovation in computational research to deliver therapies faster, more safely, and tailored to patient needs.
We recognize that the fight against sepsis transcends acute care and is about leveraging innovation in computational research to deliver therapies faster, more safely, and tailored to patient needs.
PROMOTE is a cutting-edge EU project shaping the future of prostate cancer detection and treatment.
🎓 Meet Louiza, who is investigating synthetic lethality - targeting gene interactions that selectively kill cancer cells.
Stay tuned as we share further insights from this exciting collaboration!
🎓 Meet Louiza, who is investigating synthetic lethality - targeting gene interactions that selectively kill cancer cells.
Stay tuned as we share further insights from this exciting collaboration!
September 10, 2025 at 8:00 AM
PROMOTE is a cutting-edge EU project shaping the future of prostate cancer detection and treatment.
🎓 Meet Louiza, who is investigating synthetic lethality - targeting gene interactions that selectively kill cancer cells.
Stay tuned as we share further insights from this exciting collaboration!
🎓 Meet Louiza, who is investigating synthetic lethality - targeting gene interactions that selectively kill cancer cells.
Stay tuned as we share further insights from this exciting collaboration!